Compare IQ & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQ | CYRX |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | China | United States |
| Employees | N/A | 1100 |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.3M | 814.9M |
| IPO Year | 2017 | 2008 |
| Metric | IQ | CYRX |
|---|---|---|
| Price | $1.01 | $16.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $2.91 | ★ $13.31 |
| AVG Volume (30 Days) | ★ 9.0M | 440.9K |
| Earning Date | 05-18-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $0.28 | $11.06 |
| Revenue Next Year | $3.54 | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.86 | $7.61 |
| 52 Week High | $2.72 | $17.20 |
| Indicator | IQ | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.53 | 61.56 |
| Support Level | $0.99 | $14.55 |
| Resistance Level | $1.23 | $16.87 |
| Average True Range (ATR) | 0.07 | 0.55 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 49.98 | 86.56 |
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.